Laboratorio Reig Jofre S.A. Right represents a derivative security tied to Laboratorio Reig Jofre S.A., a prominent Spanish pharmaceutical company. This financial instrument typically gives holders the right, but not the obligation, to acquire newly issued shares of Laboratorio Reig Jofre S.A. under specific terms, often related to capital increases or corporate actions. Laboratorio Reig Jofre S.A. is known for its focus on the research, development, manufacture, and marketing of pharmaceutical products and healthcare specialties. The company operates across three main business areas: pharmaceutical technologies—specializing in sterile injectables and antibiotics; specialty pharmacare—targeting dermatology and osteoarticular health; and consumer healthcare, including OTC products and dietary supplements, most notably under the Forté Pharma brand. With a substantial presence in Europe and commercial partners in over 70 countries, Laboratorio Reig Jofre S.A. plays a significant role in providing pharmaceutical solutions globally. A right, such as this, is typically issued on a temporary basis and is traded separately from the company’s ordinary shares, providing existing shareholders a mechanism to maintain their proportional ownership during equity offerings.